CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Dong-A Socio Holdings Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Dong-A Socio Holdings Co Ltd
64, Cheonho-daero, Dongdaemun-gu
Phone: +82 29208114p:+82 29208114 SEOUL, 02587  South Korea Ticker: 000640000640
Business Summary
Dong-A Socio Holdings Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through six segments. The General Pharmaceutical and Quasi-Drug segment manufactures and sells products such as tonics, vitamins, cold remedies, and oral hygiene products. The Logistic segment is mainly engaged in freight, courier, car transportation, freight warehousing and leasing business. The Packaging Container and Bottled Water segment provides glass, glass products, bottled water and other beverages. The Biosimilar and Contract Manufacture segment is involved in the contract manufacture and development of biosimilar pharmaceuticals. The Holding Company segment is mainly engaged in holding company operations and management consulting services. The Other segment is involved in information technology solution and real estate development business.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
4212 Local trucking without storage
3221 Glass containers
1542 General contractors-nonresidential buildings, other than industrial
8731 Commercial physical and biological research
2099 Food preparations, not elsewhere classified
7373 Computer integrated systems design
7379 Computer related services, not elsewhere classified
6719 Offices of holding companies, not elsewhere classified
5149 Groceries and related products, not elsewhere classified
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman, Chief Scientific Officer Jeong SeokKang 61 1/1/2023 3/20/2009
President, Chief Executive Officer, Director Min YeongKim 53 8/8/2024 1/1/2016
Chief Financial Officer, Assistant Managing Director Seung HyeonGoh 50 1/1/2023 1/1/2021
7 additional Officers and Directors records available in full report.

Business Names
Business Name
000640
Dong-A Pharmaceutical Co. Ltd.
Dong-A Pharmaceutical Co., Ltd.

General Information
Number of Employees: 273 (As of 12/31/2015)
Outstanding Shares: 6,628,788 (As of 4/15/2026)
Shareholders: 10,223
Stock Exchange: KRX
Fax Number: +82 29530336


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, May 13, 2026